Significant correlation found between vitreous human biomarkers and Alzheimer's disease

by Boston Medical CenterBoxplots of vitreous fluid biomarkers levels of total Tau, by study groups, compared using Kruskal-Wallis rank sum test withpvalues adjusted for multiple compa

Updated on: April 29,2024

Significant correlation found between vitreous human biomarkers and Alzheimer's disease

by Boston Medical CenterBoxplots of vitreous fluid biomarkers levels of total Tau, by study groups, compared using Kruskal-Wallis rank sum test withpvalues adjusted for multiple compa

Updated on:April 29,2024

Snake venom may hold key to breaking down plaques that cause Alzheimer's disease

by Monash UniversityA toxic protein called amyloid beta is thought to play a key role in the onset of Alzheimer's disease. In healthy people, amyloid beta is degraded by enzymes as it forms.

Updated on: February 28,2024

Snake venom may hold key to breaking down plaques that cause Alzheimer's disease

by Monash UniversityA toxic protein called amyloid beta is thought to play a key role in the onset of Alzheimer's disease. In healthy people, amyloid beta is degraded by enzymes as it forms.

Updated on:February 28,2024

The search for early markers of Alzheimer's Disease

by Ríona Mc Ardle,Public Library of ScienceRegional MRI predictors of MCI-to-dementia progression. Figure courtesy Korolev et al. via PLOS One.This eloquent quote by V.S. Ramachandran expresses

Updated on: February 28,2024

The search for early markers of Alzheimer's Disease

by Ríona Mc Ardle,Public Library of ScienceRegional MRI predictors of MCI-to-dementia progression. Figure courtesy Korolev et al. via PLOS One.This eloquent quote by V.S. Ramachandran expresses

Updated on:February 28,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024

Uncovering the molecular mechanism behind synapse loss in Alzheimer's disease

by Korea Brain Research InstituteCredit: Unsplash/CC0 Public DomainKorea Brain Research Institute (KBRI, Pann-Ghill Suh (President)) announced that Dr. Kea Joo Lee and Dr. You-Na Jang of the Neural Ci

Updated on: July 01,2024

Uncovering the molecular mechanism behind synapse loss in Alzheimer's disease

by Korea Brain Research InstituteCredit: Unsplash/CC0 Public DomainKorea Brain Research Institute (KBRI, Pann-Ghill Suh (President)) announced that Dr. Kea Joo Lee and Dr. You-Na Jang of the Neural Ci

Updated on:July 01,2024

rTMS as a treatment for Veterans with cognitive impairment and multiple co-morbidities

by IOS PressSchematic of a typical rTMS setup. Credit: Dr. ChengCurrent treatments for Alzheimer's disease are of limited effectiveness and do not halt the progression of the disease and asso

Updated on: March 09,2024

rTMS as a treatment for Veterans with cognitive impairment and multiple co-morbidities

by IOS PressSchematic of a typical rTMS setup. Credit: Dr. ChengCurrent treatments for Alzheimer's disease are of limited effectiveness and do not halt the progression of the disease and asso

Updated on:March 09,2024

Cracking the code for cerebellar movement disorders

byTexas Children's HospitalSupervised classifier model predicts mouse phenotype based on spike signatures. Credit:eLife(2024). DOI: 10.7554/eLife.91483.2The cerebellum is a regio

Updated on: July 05,2024

Cracking the code for cerebellar movement disorders

byTexas Children's HospitalSupervised classifier model predicts mouse phenotype based on spike signatures. Credit:eLife(2024). DOI: 10.7554/eLife.91483.2The cerebellum is a regio

Updated on:July 05,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on: February 28,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on:February 28,2024

Benzodiazepines increase mortality in persons with Alzheimer's disease

by University of Eastern FinlandBenzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from

Updated on: March 07,2024

Benzodiazepines increase mortality in persons with Alzheimer's disease

by University of Eastern FinlandBenzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from

Updated on:March 07,2024

'Epigenetic landscape' is protective in normal aging, impaired in Alzheimer's disease

by Perelman School of Medicine at the University of PennsylvaniaCoronal section of human brain indicating the lateral temporal lobe (red circle) used in this study. Credit: Coronal section of hum

Updated on: March 13,2024

'Epigenetic landscape' is protective in normal aging, impaired in Alzheimer's disease

by Perelman School of Medicine at the University of PennsylvaniaCoronal section of human brain indicating the lateral temporal lobe (red circle) used in this study. Credit: Coronal section of hum

Updated on:March 13,2024

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne

Updated on: March 07,2024

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne

Updated on:March 07,2024

Hyaluronic acid lip fillers safe for patients with systemic sclerosis, study finds

by Sarah L. Spaulding,Yale UniversitySystemic sclerosis study participants before and after treatment with hyaluronic acid filler. Credit:JAAD Case Reports(2024). DOI: 10.1016/j.jdcr

Updated on: August 01,2024

Hyaluronic acid lip fillers safe for patients with systemic sclerosis, study finds

by Sarah L. Spaulding,Yale UniversitySystemic sclerosis study participants before and after treatment with hyaluronic acid filler. Credit:JAAD Case Reports(2024). DOI: 10.1016/j.jdcr

Updated on:August 01,2024